Item 5.07 Submission of Matters to a Vote of Security Holders

On June 3, 2020, Biogen Inc. (the "Company") held its 2020 Annual Meeting of Stockholders. The final voting results for this meeting are as follows:



1.      Stockholders elected twelve nominees to the Board of Directors to serve
        for a one-year term extending until the 2021 annual meeting of
        stockholders and their successors are duly elected and qualified, with
        the votes cast as follows:


Nominee                 Votes For     Votes Against    Abstentions    Broker Non-Votes

Alexander J. Denner 109,578,677 24,115,678 139,938 11,528,918 Caroline D. Dorsa 114,393,693 19,315,657 124,943 11,528,918 William A. Hawkins 116,756,044 16,923,793 154,456 11,528,918 Nancy L. Leaming 114,725,734 18,984,269 124,290 11,528,918 Jesus B. Mantas 114,803,547 18,888,530 142,216 11,528,918 Richard C. Mulligan 114,489,400 19,208,581 136,312 11,528,918 Robert W. Pangia 110,981,253 22,721,168 131,872 11,528,918 Stelios Papadopoulos 105,915,276 26,978,888 940,129 11,528,918 Brian S. Posner 114,139,581 19,556,217 138,495 11,528,918 Eric K. Rowinsky 106,914,175 26,782,624 137,494 11,528,918 Stephen A. Sherwin 116,603,647 17,082,790 147,856 11,528,918 Michel Vounatsos 114,368,788 19,205,777 259,728 11,528,918






2.      Stockholders ratified the selection of PricewaterhouseCoopers LLP as the
        Company's independent registered public accounting firm for the fiscal
        year ending December 31, 2020, with the votes cast as follows:

Votes For Votes Against Abstentions Broker Non-Votes 142,634,499 2,547,394 181,318

            -




3.      Stockholders approved the advisory vote on executive compensation, with
        the votes cast as follows:


 Votes For    Votes Against   Abstentions   Broker Non-Votes
110,965,295    22,518,791       350,207        11,528,918


Item 9.01   Financial Statements and Exhibits.
(d)  Exhibits
Exhibit No.       Description
                  Cover Page Interactive Data File (embedded within the Inline
104               XBRL document)

--------------------------------------------------------------------------------





                                   Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Biogen Inc.
By: /s/ F. Ty Edmondson
F. Ty Edmondson
Chief Corporate and Compliance Counsel and Assistant Secretary
Date: June 5, 2020

© Edgar Online, source Glimpses